Free Trial

Canopy Growth (CGC) Competitors

Canopy Growth logo
$1.05 +0.02 (+1.94%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.06 +0.01 (+0.95%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, XERS, NUVB, and TRVI

Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), Xeris Biopharma (XERS), Nuvation Bio (NUVB), and Trevi Therapeutics (TRVI).

Canopy Growth vs. Its Competitors

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

In the previous week, Canopy Growth had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.51 beat Aurora Cannabis' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aurora Cannabis has a net margin of 1.32% compared to Canopy Growth's net margin of -195.76%. Aurora Cannabis' return on equity of 0.13% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-195.76% -88.54% -40.78%
Aurora Cannabis 1.32%0.13%0.10%

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 1.3% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$225.65M0.95-$429.86M-$4.04-0.26
Aurora Cannabis$246.72M1.02$1.63M$0.1140.73

Canopy Growth has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

Summary

Aurora Cannabis beats Canopy Growth on 13 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$211.30M$10.40B$5.48B$9.51B
Dividend YieldN/A1.99%4.73%4.09%
P/E Ratio-0.2618.4228.6723.80
Price / Sales0.9529.01373.9066.58
Price / CashN/A22.3135.4557.96
Price / Book0.553.478.275.55
Net Income-$429.86M$234.77M$3.24B$259.03M
7 Day Performance-7.89%-4.82%-3.69%-4.59%
1 Month Performance-11.76%1.80%4.33%4.46%
1 Year Performance-84.02%-12.51%25.95%18.03%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGC
Canopy Growth
0.6272 of 5 stars
$1.05
+1.9%
N/A-84.5%$211.30M$225.65M-0.263,150News Coverage
Upcoming Earnings
ACB
Aurora Cannabis
0.3762 of 5 stars
$4.70
+3.8%
N/A-26.0%$264.38M$246.72M42.731,130Upcoming Earnings
CRON
Cronos Group
2.3244 of 5 stars
$2.09
+4.0%
N/A-17.0%$806.07M$117.61M16.08450Upcoming Earnings
OGI
Organigram Global
1.1589 of 5 stars
$1.46
+0.7%
N/A-15.3%$195.55M$117.47M14.60860News Coverage
SNDL
SNDL
2.6343 of 5 stars
$1.58
+2.6%
$4.00
+153.2%
-25.3%$415.19M$671.81M-5.452,516Trending News
Earnings Report
Analyst Revision
TLRY
Tilray Brands
2.8903 of 5 stars
$0.67
+8.4%
$1.92
+184.6%
-71.4%$677.88M$788.94M-0.642,650Trending News
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision
Gap Down
VFF
Village Farms International
2.7654 of 5 stars
$1.38
+3.8%
N/A+38.7%$155.03M$336.18M-3.831,400Positive News
STZ
Constellation Brands
4.6223 of 5 stars
$167.96
-1.5%
$213.74
+27.3%
-32.2%$29.61B$10.96B-70.2810,600Positive News
XERS
Xeris Biopharma
3.383 of 5 stars
$5.14
+0.6%
$6.25
+21.6%
+121.4%$803.79M$203.07M-17.13290News Coverage
Positive News
Upcoming Earnings
Short Interest ↑
NUVB
Nuvation Bio
2.2856 of 5 stars
$2.36
+2.4%
$7.17
+204.3%
-37.4%$801.31M$7.87M-1.0060News Coverage
Upcoming Earnings
TRVI
Trevi Therapeutics
2.4543 of 5 stars
$6.82
-0.6%
$20.88
+206.1%
+136.5%$799.92MN/A-15.1620News Coverage
Positive News
Upcoming Earnings
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:CGC) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners